Christopher Halliday

BET inhibition blocks inflammation-induced cardiac dysfunction and SARS-CoV-2 infection

Richard J. Mills, Sean J. Humphrey, Patrick R.J. Fortuna et al. · Cell · 2021 · 209 citations · Full text

Inflammation, Sars-cov-2 Infection, Immunology +3

Avian flu: the creation of expectations in the interplay between science and the media

Brigitte Nerlich, Christopher Halliday · Sociology of Health & Illness · 2007 · 180 citations · Full text

Apabetalone (RVX-208) reduces vascular inflammation in vitro and in CVD patients by a BET-dependent epigenetic mechanism

Laura Tsujikawa, Li Fu, Shovon Das et al. · Clinical Epigenetics · 2019 · 117 citations · Full text

RVX-208, a BET-inhibitor for treating atherosclerotic cardiovascular disease, raises ApoA-I/HDL and represses pathways that contribute to cardiovascular disease

Dean Gilham, Sylwia Wasiak, Laura Tsujikawa et al. · Atherosclerosis · 2016 · 112 citations · Full text

Inflammation, Metabolic Syndrome, Excess Cholesterol +12

Apabetalone downregulates factors and pathways associated with vascular calcification

Dean Gilham, Laura Tsujikawa, Christopher D. Sarsons et al. · Atherosclerosis · 2018 · 65 citations · Full text